Determination of total captopril in human plasma by gas chromatography-mass spectrometry with selected-ion monitoring after reduction of disulfides.
Captopril is liberated from covalently protein-bound disulfides and other disulfide metabolites in human plasma by reduction with tri-n-butyl-phosphine. The captopril is then treated with N-ethylmaleimide, purified on XAD-2 resin, eluted with ethyl acetate, and methylated prior to its determination by gas chromatography-mass spectrometry with selected-ion monitoring. The limit of detection is 20 ng/mL of plasma.